Baxter Recalls Sodium Chloride Injection Bags Due to Fiberglass Particulates
Baxter Healthcare is recalling 0.9% Sodium Chloride Injection bags because fiberglass particulates were identified in the product.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source text explicitly identifies the agency classification as 'Class I', which mandates a severity score of 5 according to the rubric.
Plain-English summary
Baxter Healthcare Corporation is recalling 0.9% Sodium Chloride Injection USP 500 mL VIAFLEX Plastic Containers. The recall involves 145,464 bags distributed nationwide in the United States. The specific lots affected are Y495523 and Y495523A, with an expiration date of October 31, 2027.
The reason for the recall is the presence of particulate matter, specifically identified as fiberglass, within the product. This is an FDA Class I recall, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death.
Healthcare providers and facilities should check their inventory for the affected lot numbers and stop using the product. Patients who have received this product should contact their healthcare provider if they experience any adverse effects.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Baxter Healthcare Corporation
- Category
- Drug — IV Fluids
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: Y495523
- Y495523A
- Exp 31-Oct-2027
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · SODIUM CHLORIDE
- HighSpectra sodium chloride ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighFresenius sodium chloride 1,000 mL dialysis-supplied bags recalled over sterility
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 100 mL sodium chloride freeflex bags recalled over sterility
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 250 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 250 mL saline freeflex bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- HighBaxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Same hazard · particulate matter
See all →- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAminocaproic Acid Injection Recalled for Particulate Matter Contamination
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26